首页 > 市场调查报告书 > 医疗设备

手术用器具

市场调查报告书

商品编码

1087026

生物外科全球市场预测：2022-2027

Global Biosurgery Market - Forecasts from 2022 to 2027

出版日期: 2022年04月21日 | 出版商:

Knowledge Sourcing Intelligence | 英文 124 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

全球生物外科市场从 2020 年的 30.42 亿美元增长到 2027 年的 43.57 亿美元，复合年增长率为 5.27%。

越来越多的手术和人口老龄化为全球生物外科产品市场的增长提供了潜力。慢性病和运动外科病例数量的增加也推动了全球生物外科市场的增长。各大公司在生物外科产品研发领域的高投入以及政府对新的先进研发的支持也促成了生物外科产品的主要开发和开发。

本报告对全球生物外科市场进行调查，包括市场概况、市场驱动因素和製约因素、产品类型/用途/来源/区域分析、竞争形势、企业概况等。

The global biosurgery market comprises certain products used to minimize or reduce intra- and post-surgery complications. Biosurgery products offer more efficiency and less complexity in surgery and other medical procedures. Depending on the types of products, the biosurgery market is segmented into certain types like hemostatic, anti-adhesive agents, surgical sealing agents, and bone graft substitutes. The rising number of surgery cases and increasing geriatric population is giving potential to the market growth of global biosurgery products. The population aged 65 and above or the geriatric population is widely using the help and assistance of biosurgery products. The wide application of biosurgery products in medical and surgical procedures in the geriatric population raises the demand for biosurgery products in the global market. The rising cases of surgery and operation procedures due to chronic diseases and sports surgeries are also driving the market growth of the global biosurgery market. The higher investments of major companies in the research and development section of biosurgery products also result in major developments and advancements in biosurgery products. The government's support in new advanced research and developments in biosurgery products is also boosting the global biosurgery products market. The growth and adaptation of technology in the medical field increase the global biosurgery market.

The recent outbreak of the COVID-19 pandemic has restricted the market growth of the global biosurgery market to a certain extent. The pandemic fear had made the patients have less interaction with hospitals and health centers. The fear of people visiting hospitals and clinics for certain medical procedures other than COVID resulted in the slow market growth of the global biosurgery market. The home-based health diagnosis and check-ups resulted in the restricted market growth of the global biosurgery market. The full focus of government agencies and major companies in developing and preventing COVID spread also restricted the fast growth of the research and development section of biosurgery products in the global market.

Rising Research and Development Programmes

The higher investments of major players or companies in the research and development sector of biosurgery products are boosting the market growth of the global biosurgery market. The penetration of technology or electronics in the field of biosurgery has boosted the market growth of the global biosurgery market to a certain extent. The development of advanced infused bone graft implantation developed by Medtronic PLC can be considered as one of the rising developments in the field of bone graft implantation or biosurgery products. The approval of the FDA (U.S Food and Drug Administration) for the newly developed bone graft implantation also shows the immense support of governmental agencies in the development of biosurgery products. The synthetic hydrogel technology developed by Kuros Biosurgery can also be counted as one of the major developments in the global biosurgery market. The rapid growth in the research and development sector of biosurgery products is fuelling the market growth of the global biosurgery market. The increased penetration of electronics and new technology in the medical field also resulted in new advancements and developments in the global biosurgery market. The higher competition of major players in the research and development sector of biosurgery products contributes to the rapid growth of biosurgery products in the global market.

Rising number of surgeries & cases of chronic diseases

The rising number of surgeries and an increasing number of people with chronic diseases is one of the major factors driving the market growth of the global biosurgery market. The convenience and effectiveness offered by biosurgery products result in the market growth of biosurgery products. The increasing cases of chronic diseases are contributing to the market growth of the global biosurgery market. The rising cases of cardiovascular diseases and implementation of biosurgery products in surgeries and treatment of cardiovascular diseases is giving potential to the market growth of the global biosurgery market. The surgeries and implantations in cardiovascular diseases are the major sections that widely employ the application of biosurgery products in the medical field. The rising percentage of the geriatric population is also one of the major driving factors in the growth of the global biosurgery market. The report of the United Nations states that approximately 962 million people are aged 60 or above in the world. The population growth rate of people above 60 also reports a growth rate of 3% annually. The rise in the geriatric population and increasing cases of lifestyle and chronic diseases are fuelling the growth of the global biosurgery market.

North America expected to lead the market

Geographically, the North American region is expected to lead the global biosurgery market in the forecasted years. The rising cases of chronic and lifestyle diseases and obesity problems are driving the market growth of the biosurgery market in the North American region. The presence of major players and the investment and research & development of biosurgery products is also hiking the market of biosurgery products in the North American region.

Segmentation

By Product Type

Anti-adhesive agents

Hemostatic agents

Surgical sealing agents

Bone graft substitutes

Soft Tissue Attachments

By Application

Cardiovascular and Thoracic Surgery

Neuro-Spine surgery

Orthopedic Surgery

General Surgery

Others

By Source

Natural/Biological Products

Synthetic Products

By Geography

North America

USA
Canada
Mexico

South America

Brazil
Argentina
Others

Europe

Germany
France
UK
Others

Middle East and Africa

Saudi Arabia
UAE
Others

Asia Pacific

China
India
Japan
South Korea
Taiwan
Thailand
Indonesia
Others

1. Introduction

1.1. Market Definition
1.2. Market Segmentation

2. Research Methodology

2.1. Research Data
2.2. Assumptions

3. Executive Summary

3.1. Research Highlights

4. Market Dynamics

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of End-Users
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. Global Biosurgery Market Analysis, by Product Type

5.1. Introduction
5.2. Anti-adhesive agents
5.3. Hemostatic agents
5.4. Surgical sealing agents
5.5. Bone graft substitutes
5.6. Soft Tissue attachments

6. Global Biosurgery Market Analysis, by Application

6.1. Introduction
6.2. Cardiovascular and Thoracic Surgery
6.3. Neuro-Spine surgery
6.4. Orthopedic Surgery
6.5. General Surgery
6.6. Others

7. Global Biosurgery Market Analysis, by Source

7.1. Introduction
7.2. Natural/Biological Products
7.3. Synthetic Products

8. Global Biosurgery Market Analysis, by Geography

8.1. Introduction
8.2. North America
- 8.2.1. USA
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. Germany
- 8.4.2. France
- 8.4.3. UK
- 8.4.4. Others
8.5. Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Others
8.6. Asia Pacific
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. South Korea
- 8.6.5. Taiwan
- 8.6.6. Thailand
- 8.6.7. Indonesia
- 8.6.8. Others